Recurrent dysosmia induced by pyrazinamide

Fundamental and Clinical Pharmacology

Volumn 23, Issue 5, 2009, Pages 539-541

  El Aïdli, Sihem ^a   Kastalli, Sarrah ^a   Zaïem, Ahmed ^a   Lakhoua, Ghozlane ^a   Rejeibi, Imen ^b   Loueslati, Mohamed Hedi ^a   Daghfous, Riadh ^a   Belkahia, Chalbi ^a  

^a Centre National de Pharmacovigilance   (Tunisia)

^b Dermatology Department   (Tunisia)

Author keywords

Adverse effect; Olfactory disorders; Pyrazinamide

Indexed keywords

ETHAMBUTOL; GLICLAZIDE; ISONIAZID; NIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; UNCLASSIFIED DRUG;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIABETES MELLITUS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSOSMIA; FEMALE; HUMAN; OLFACTORY DISCRIMINATION; PRIORITY JOURNAL; RECURRENT DISEASE; SMELLING; SMELLING DISORDER; TUBERCULOUS OSTEOMYELITIS;

ANTITUBERCULAR AGENTS; FEMALE; HUMANS; MIDDLE AGED; OLFACTION DISORDERS; PYRAZINAMIDE; RECURRENCE;

EID: 69949137341     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2009.00736.x     Document Type: Article

References (11)

1. Sweetman S.C. Martindale: the complete drug reference, 34th edn, Pharmaceutical Press, London, 2005.
2. Papastavros T., Dolovich L.R., Holbrook A., Whitehead L., Loeb M. Adverse events associated with pyrazinamide and levofloxacin in the treatment of latent multidrug-resistant tuberculosis. Can. Med. Assoc. J. (2002) 167 131 136.
3. McIlleron H., Norman J., Kanyok T.P., Fourie P.B., Horton J., Smith P.J. Elevated gatifloxacin and reduced rifampicin concentrations in a single-dose interaction study amongst healthy volunteers. J. Antimicrob. Chemother. (2007) 60 1398 1401.
4. Bégaud B., Evreux J.C., Jouglard J., Lagier G. Imputabilité des effets inattendus ou toxiques des médicaments: actualisation de la méthode utilisée en France. Thérapie (1985) 40 111 118.
5. Nores J.M., Biacabe B., Bonfils P. Olfactory disorders and general pathologies. Analysis and literature review. Rev. Med. Intern. (2000) 21 95 104. (Pubitemid 30051289)
6. Norès J.M., Biacabe B., Bonfils P. Olfactory disorders due to medicinal drugs: an analysis and review of the literature. Rev. Med. Intern. (2000) 21 972 977. (Pubitemid 30835631)
7. Kharoubi S. Drug induced anosmia with nifedipine. Presse Med. (2003) 32 1269 1272.
8. Doty R.L., Bromley S.M. Effects of drugs on olfaction and taste. Otolaryngol. Clin. North Am. (2004) 37 1229 1254.
9. Henkin R.L. Drug-induced taste and smell disorders. Incidence, mechanisms and management related primarily to treatment of sensory receptor dysfunction. Drug Saf. (1994) 11 318 377.
10. Ackerman B.H., Kasbekar N. Disturbances of taste and smell induced by drugs. Pharmacotherapy (1997) 17 482 496.
11. Ruef C., Blaser J. Miscellaneous antibacterial drugs: aminogycosides, chloramphenicol and thiamphenicol, fluoroquinolones, glycopeptides, in : Dukes M.W.G., Aronson J.K. (Eds Meyler's side effects of drugs, 14th edn, Elsevier, Amsterdam, 2000, pp. 837 870.